Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)-Reference-Cited by-同舟云学术

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)

Published:2018-10-29 Issue:6 Volume:21 Page:721-728
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Zhao Y.,Qiao G.,Wang X.,Song Y.,Zhou X.,Jiang N.,Zhou L.,Huang H.,Zhao J.,Morse M. A.,Hobeika A.,Ren J.^ORCID,Lyerly H. K.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-018-1968-3.pdf

Reference35 articles.

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. Juergens R, Brahmer J. Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how? Curr Oncol Rep. 2007;9:255–64.

3. Choudhury A, Palma M, Mellstedt H. The future of cancer vaccines for non-small-cell lung cancer: ongoing trials. Clin Lung Cancer. 2008;9(Suppl 1):S37–44.

4. Till BG, Jensen MC, Wang J, et al. Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood. 2008;112:2261–71.

5. Rizvi NA, Hellmann MD, Snyder A, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348:124–8.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs;Scientific Reports;2024-06-11

2. Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy;Vaccines;2024-05-05

3. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer;Journal of Interferon & Cytokine Research;2024-03-01

4. Peripheral Blood CD8⁺ CD28⁺ T Cells as an Independent Predictor of Treatment Response and Survival After Concurrent Chemoradiotherapy in Pediatric High-Grade Glioma Patients;Clinical Medicine Insights: Oncology;2024-01

5. Advances of cell therapy in lung cancer: a narrative review;Journal of Thoracic Disease;2023-12